Lilly’s Alzheimer’s super drug to be approved ‘any day’

LONDON: The pharma giant behind breakthrough Alzheimer’s drug Donanemab expects approval to come from US…
LONDON: The pharma giant behind breakthrough Alzheimer’s drug Donanemab expects approval to come from US…